Literature DB >> 26354435

Proteinase-activated receptor 2 promotes cancer cell migration through RNA methylation-mediated repression of miR-125b.

Lan Yang1, Yiming Ma1, Wenxiao Han1, Weiwei Li1, Liang Cui2, Xinhua Zhao1, Yantao Tian2, Zhixiang Zhou3, Wengong Wang4, Hongying Wang5.   

Abstract

Proteinase activated-receptor 2 (PAR2) participates in cancer metastasis promoted by serine proteinases. The current study aimed to test the molecular mechanism by which PAR2 promotes cancer cell migration. In different cancer cells, activation of PAR2 by activating peptide (PAR2-AP) dramatically increased cell migration, whereas knock down of PAR2 inhibited cellular motility. The PAR2 activation also repressed miR-125b expression while miR-125b mimic successfully blocked PAR2-induced cell migration. Moreover, Grb associated-binding protein 2 (Gab2) was identified as a novel target gene of miR-125b and it mediated PAR2-induced cell migration. The correlation of PAR2 with miR-125b and Gab2 was further supported by the findings obtained from human colorectal carcinoma specimens. Remarkably, knock down of NOP2/Sun domain family, member 2 (NSun2), a RNA methyltransferase, blocked the reduction in miR-125b induced by PAR2. Furthermore, PAR2 activation increased the level of N(6)-methyladenosine (m(6)A)-containing pre-miR-125b in NSun2-dependent manner. Taken together, our results demonstrated that miR-125b mediates PAR2-induced cancer cell migration by targeting Gab2 and that NSun2-dependent RNA methylation contributes to the down-regulation of miR-125b by PAR2 signaling. These findings suggest a novel epigenetic mechanism by which microenvironment regulates cancer cell migration by altering miRNA expression.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Gab2; RNA methylation; cell biology; cell signaling; mi-125b; microRNA (miRNA); migration; proteinase-activated receptor 2; tumor metastasis

Mesh:

Substances:

Year:  2015        PMID: 26354435      PMCID: PMC4646319          DOI: 10.1074/jbc.M115.667717

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Mast cells have a protumorigenic role in human thyroid cancer.

Authors:  R M Melillo; V Guarino; E Avilla; M R Galdiero; F Liotti; N Prevete; F W Rossi; F Basolo; C Ugolini; A de Paulis; M Santoro; G Marone
Journal:  Oncogene       Date:  2010-08-23       Impact factor: 9.867

2.  Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b.

Authors:  Gary K Scott; Andrei Goga; Dipa Bhaumik; Crystal E Berger; Christopher S Sullivan; Christopher C Benz
Journal:  J Biol Chem       Date:  2006-11-16       Impact factor: 5.157

3.  Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation.

Authors:  Roberta Caruso; Francesco Pallone; Daniele Fina; Valentina Gioia; Ilaria Peluso; Flavio Caprioli; Carmine Stolfi; Alessandra Perfetti; Luigi Giusto Spagnoli; Giampiero Palmieri; Thomas T Macdonald; Giovanni Monteleone
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

4.  Clinical significance of GAB2, a scaffolding/docking protein acting downstream of EGFR in human colorectal cancer.

Authors:  Tae Matsumura; Keishi Sugimachi; Yusuke Takahashi; Ryutaro Uchi; Genta Sawada; Masami Ueda; Hidenari Hirata; Shotaro Sakimura; Hiroki Ueo; Yuki Takano; Junji Kurashige; Yoshiaki Shinden; Hidetoshi Eguchi; Tomoya Sudo; Hirofumi Yamamoto; Yuichiro Doki; Masaki Mori; Koshi Mimori
Journal:  Ann Surg Oncol       Date:  2014-07-17       Impact factor: 5.344

5.  Protease-activated receptor-2 regulates cell proliferation and enhances cyclooxygenase-2 mRNA expression in human pancreatic cancer cells.

Authors:  Kazuhiro Yada; Kohei Shibata; Toshifumi Matsumoto; Masayuki Ohta; Shigeo Yokoyama; Seigo Kitano
Journal:  J Surg Oncol       Date:  2005-02-01       Impact factor: 3.454

6.  Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis.

Authors:  Weiying Zhou; Miranda Y Fong; Yongfen Min; George Somlo; Liang Liu; Melanie R Palomares; Yang Yu; Amy Chow; Sean Timothy Francis O'Connor; Andrew R Chin; Yun Yen; Yafan Wang; Eric G Marcusson; Peiguo Chu; Jun Wu; Xiwei Wu; Arthur Xuejun Li; Zhuo Li; Hanlin Gao; Xiubao Ren; Mark P Boldin; Pengnian Charles Lin; Shizhen Emily Wang
Journal:  Cancer Cell       Date:  2014-04-14       Impact factor: 31.743

7.  Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice.

Authors:  Henri H Versteeg; Florence Schaffner; Marjolein Kerver; Lesley G Ellies; Patricia Andrade-Gordon; Barbara M Mueller; Wolfram Ruf
Journal:  Cancer Res       Date:  2008-09-01       Impact factor: 12.701

8.  Protease-activated receptor-2 expression and the role of trypsin in cell proliferation in human pancreatic cancers.

Authors:  Tetsuo Ohta; Koichi Shimizu; Shuangqin Yi; Hiroyuki Takamura; Kohji Amaya; Hirohisa Kitagawa; Masato Kayahara; Itasu Ninomiya; Sachio Fushida; Takashi Fujimura; Gen-Ichi Nishimura; Koichi Miwa
Journal:  Int J Oncol       Date:  2003-07       Impact factor: 5.650

9.  Amplification of MMP-2 and MMP-9 production by prostate cancer cell lines via activation of protease-activated receptors.

Authors:  Susan R Wilson; Sandra Gallagher; Kate Warpeha; Susan J Hawthorne
Journal:  Prostate       Date:  2004-07-01       Impact factor: 4.104

10.  A miRNA signature of chemoresistant mesenchymal phenotype identifies novel molecular targets associated with advanced pancreatic cancer.

Authors:  Alakesh Bera; Kolaparthi VenkataSubbaRao; Muthu Saravanan Manoharan; Ping Hill; James W Freeman
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

View more
  22 in total

1.  BRAF inhibition upregulates a variety of receptor tyrosine kinases and their downstream effector Gab2 in colorectal cancer cell lines.

Authors:  Ricarda Herr; Sebastian Halbach; Miriam Heizmann; Hauke Busch; Melanie Boerries; Tilman Brummer
Journal:  Oncogene       Date:  2018-01-12       Impact factor: 9.867

2.  Protease activated receptor 2 mediates tryptase-induced cell migration through MYO10 in colorectal cancer.

Authors:  Xiaoli Zhang; Qing Fang; Yiming Ma; Shuangmei Zou; Qian Liu; Hongying Wang
Journal:  Am J Cancer Res       Date:  2019-09-01       Impact factor: 6.166

Review 3.  One Stone, Two Birds: N6-Methyladenosine RNA Modification in Leukemia Stem Cells and the Tumor Immune Microenvironment in Acute Myeloid Leukemia.

Authors:  Xianfeng Ouyang; Yuping Gong
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

Review 4.  N6-methyladenosine RNA modification and its interaction with regulatory non-coding RNAs in colorectal cancer.

Authors:  Yiling Ge; Tong Liu; Chuntao Wang; Yanqiu Zhang; Siyi Xu; Yiyi Ren; Yanlu Feng; Lihong Yin; Yuepu Pu; Geyu Liang
Journal:  RNA Biol       Date:  2021-10-21       Impact factor: 4.766

5.  β-arrestin-dependent PI(4,5)P2 synthesis boosts GPCR endocytosis.

Authors:  Seung-Ryoung Jung; Yifei Jiang; Jong Bae Seo; Daniel T Chiu; Bertil Hille; Duk-Su Koh
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-27       Impact factor: 11.205

Review 6.  Methylated DNA/RNA in Body Fluids as Biomarkers for Lung Cancer.

Authors:  Yan Lu; Shulin/Sl Li; Shiguo/Sg Zhu; Yabin/Yb Gong; Jun/J Shi; Ling/L Xu
Journal:  Biol Proced Online       Date:  2017-03-17       Impact factor: 3.244

Review 7.  Epigenetics: Roles and therapeutic implications of non-coding RNA modifications in human cancers.

Authors:  Dawei Rong; Guangshun Sun; Fan Wu; Ye Cheng; Guoqiang Sun; Wei Jiang; Xiao Li; Yi Zhong; Liangliang Wu; Chuanyong Zhang; Weiwei Tang; Xuehao Wang
Journal:  Mol Ther Nucleic Acids       Date:  2021-05-01       Impact factor: 8.886

8.  Ascites promotes cell migration through the repression of miR-125b in ovarian cancer.

Authors:  Lan Yang; Xiaoli Zhang; Yiming Ma; Xinhua Zhao; Bin Li; Hongying Wang
Journal:  Oncotarget       Date:  2017-04-05

Review 9.  Multiple functions of m6A RNA methylation in cancer.

Authors:  Yutian Pan; Pei Ma; Yu Liu; Wei Li; Yongqian Shu
Journal:  J Hematol Oncol       Date:  2018-03-27       Impact factor: 17.388

10.  The Protease Activated Receptor2 Promotes Rab5a Mediated Generation of Pro-metastatic Microvesicles.

Authors:  Kaushik Das; Ramesh Prasad; Sreetama Roy; Ashis Mukherjee; Prosenjit Sen
Journal:  Sci Rep       Date:  2018-05-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.